ALENDRONATE SODIUM
| Brand name | BINOSTO |
|---|---|
| Active ingredient | ALENDRONATE SODIUM |
| Strength | EQ 70MG BASE |
| Dosage form | TABLET, EFFERVESCENT |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | March 2012 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9592195 | December 2031 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.